Beta-lactamases of Mycobacterium tuberculosis and Mycobacterium kansasii.

C. Segura, M. Salvadó

Research output: Contribution to journalReview articleResearchpeer-review


Re-emergence of infectious diseases caused by mycobacteria as well as the emergence of multiresistant strains of Mycobacterium has promoted the research on the use of beta-lactames in the treatment of such diseases. Mycobacteria produce beta-lactamases: M. tuberculosis produces a wide-spectrum beta-lactamase whose behaviour mimicks those of Gram-negative bacteria. M. kansasii produces also beta-lactamase which can be inhibited by clavulanic acid. An overview on beta-lactamases from both species is reported.
Original languageEnglish
Pages (from-to)331-336
JournalMicrobiologia SEM
Issue number3
Publication statusPublished - 1 Jan 1997


Dive into the research topics of 'Beta-lactamases of Mycobacterium tuberculosis and Mycobacterium kansasii.'. Together they form a unique fingerprint.

Cite this